Pichia pastoris Surface Display System for Homogeneous Glycans
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Pichia pastoris strains used for recombinant protein production often exhibit antigenic and rapidly cleared N-glycosylated proteins due to high mannose oligosaccharides, making them unsuitable for pharmaceutical applications, and existing strains like M5-Blast are unstable due to genomic rearrangements.
Innovation Solution
Development of novel Pichia pastoris strains, such as SuperMan5, with a mutant OCH1 allele that localizes the OCH1 protein to the Golgi apparatus, producing substantially homogeneous N-glycans, and vectors like pJGG-display for cell surface display, enabling stable expression and improved protein accessibility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If Pichia pastoris strains are used for recombinant protein production, then high expression levels and ease of manipulation are achieved, but the produced proteins exhibit antigenic properties and rapid clearance due to high mannose oligosaccharides
Solution Approach 1:
The patent modifies the glycosylation parameters of P. pastoris by introducing mutant OCH1 alleles that alter the mannosyltransferase enzyme activity. This changes the N-glycan structure from high mannose types (Man8-11GlcNAc2) to homogeneous low mannose types (Man5GlcNAc2), thereby reducing antigenicity while maintaining high expression levels of recombinant proteins
Solution Approach 2:
The patent creates a stable host strain (SuperMan5) that inherently produces human-like N-glycans, eliminating the need for complex post-production purification steps to remove antigenic high mannose glycans. This disposable strain can be directly used for pharmaceutical protein production without additional processing
2Object-affected harmful factors
If the M5-Blast strain is used to modify N-glycosylation pathway, then some reduction in high mannose oligosaccharides is achieved, but the strain is unstable due to genomic rearrangements
Solution Approach 1:
The patent removes the unstable disruption cassette from the OCH1 locus and replaces it with a stable mutant OCH1 allele. This extracts the problematic element (the cassette prone to rearrangement) and replaces it with a clean, stable genetic modification that permanently alters the glycosylation pathway without genomic instability
Solution Approach 2:
The patent segments the OCH1 gene into specific mutant alleles (OCH1Δ1, OCH1Δ2, OCH1Δ3) with defined deletions. This segmentation allows precise control over the mannosyltransferase activity and creates genetically stable strains with predictable glycosylation phenotypes, eliminating the rearrangement issues of the M5-Blast strain
3Ease of operation
If cell surface display techniques are implemented, then protein accessibility and binding efficiency are improved, but the complexity of strain engineering increases
Solution Approach 1:
The patent creates a universal P. pastoris display system where the SuperMan5 strain can express any recombinant protein with homogeneous N-glycans on the cell surface. The strain serves multiple functions: it provides stable genetic manipulation, produces human-like glycans, enables surface display, and facilitates easy isolation through yeast surface display techniques, reducing overall system complexity
Data Source
AI summary
This disclosure relates to novel Pichia pastoris display systems, e.g., display systems featuring the Pichia pastoris strains (such as SuperMan5) with substantially homogeneous N-glycans displayed on cell surface proteins.